Beta test our new site.
|
Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||||||
---|---|---|---|---|---|---|---|---|---|
First Received Date ICMJE | September 28, 2005 | ||||||||
Last Updated Date | February 7, 2010 | ||||||||
Start Date ICMJE | December 2005 | ||||||||
Estimated Primary Completion Date | December 2010 (final data collection date for primary outcome measure) | ||||||||
Current Primary Outcome Measures ICMJE |
PSS-i [ Time Frame: 15 weeks and 1-year follow-up ] [ Designated as safety issue: No ] | ||||||||
Original Primary Outcome Measures ICMJE | Same as current | ||||||||
Change History | Complete list of historical versions of study NCT00229307 on ClinicalTrials.gov Archive Site | ||||||||
Current Secondary Outcome Measures ICMJE | |||||||||
Original Secondary Outcome Measures ICMJE | |||||||||
Current Other Outcome Measures ICMJE | |||||||||
Original Other Outcome Measures ICMJE | |||||||||
Descriptive Information | |||||||||
Brief Title ICMJE | Prolonged Exposure (PE) Treatment for Post Traumatic Stress Disorder (PTSD) 20 Minutes Versus 40 Minutes | ||||||||
Official Title ICMJE | |||||||||
Brief Summary | Comparing the efficacy of 40 minutes PE treatment to 20 minutes of the same treatment |
||||||||
Detailed Description | |||||||||
Study Type ICMJE | Interventional | ||||||||
Study Phase | |||||||||
Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
||||||||
Condition ICMJE | PTSD | ||||||||
Intervention ICMJE |
|
||||||||
Study Arms |
|
||||||||
Publications * | |||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
Recruitment Information | |||||||||
Recruitment Status ICMJE | Recruiting | ||||||||
Estimated Enrollment ICMJE | 20 | ||||||||
Estimated Completion Date | December 2010 | ||||||||
Estimated Primary Completion Date | December 2010 (final data collection date for primary outcome measure) | ||||||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
Gender | Both | ||||||||
Ages | 18 Years to 65 Years | ||||||||
Accepts Healthy Volunteers | No | ||||||||
Contacts ICMJE |
|
||||||||
Location Countries ICMJE | Israel | ||||||||
Administrative Information | |||||||||
NCT Number ICMJE | NCT00229307 | ||||||||
Other Study ID Numbers ICMJE | SHEBA-05-3709-JZ-CTIL | ||||||||
Has Data Monitoring Committee | No | ||||||||
Responsible Party | Prof. Joseph Zohar, Chaim Sheba Medical Center | ||||||||
Study Sponsor ICMJE | Sheba Medical Center | ||||||||
Collaborators ICMJE | |||||||||
Investigators ICMJE |
|
||||||||
Information Provided By | Sheba Medical Center | ||||||||
Verification Date | February 2010 | ||||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |